DRAP and CCP Sign MoU to Strengthen Oversight of Pakistan’s Pharma Market
Pakistan has taken a major step toward improving transparency, fair competition, and consumer protection in its pharmaceutical and therapeutic goods sector. In a significant development, the Drug Regulatory Authority of Pakistan (DRAP) and the Competition Commission of Pakistan (CCP) have signed a Memorandum of Understanding (MoU) aimed at boosting coordination and enhancing regulatory oversight. The […]